Skip to content
Screener

Cardiol Therapeutics CRDL Q3 2026 earnings

Reported November 12, 2026 · Before market open

EPS-$0.08Miss by $0.02
EPS estimate-$0.06

Next report

Date not yet announced

FAQ

When did Cardiol Therapeutics report Q3 2026 earnings?
Cardiol Therapeutics (CRDL) reported Q3 2026 earnings on November 12, 2026 before market open.
What were Cardiol Therapeutics's Q3 2026 revenue and EPS?
Cardiol Therapeutics reported eps of $-0.08 for Q3 2026.
Did Cardiol Therapeutics beat estimates in Q3 2026?
EPS missed the consensus estimate of $-0.06 by $0.02.
How did Cardiol Therapeutics's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 11.1% from $-0.09.